[1]Coleman RE. Skeletal complications of malignancy[J]. Cancer, 1997, 80(suppl l8): 1 588. [2]Ando A, Ando I, Tonami N, et al. 177Lu-EDTMP: a potential therapeutic bone agent[J]. Nucl Med Commun, 1998, 19(60): 587-591. [3]Dvorakova Z, Henkelmann R, Lin X, et al. Production of 177Lu at the new research reactor FRM-Ⅱ: Irradiation yield of 176Lu(n,gamma)177Lu[J]. Appl Radiat Isot, 2008, 66(2): 147-151. [4]Le VS. Specific radioactivity of neutron induced radioisotopes: assessment methods and application for medically useful 177Lu production as a case[J]. Molecules, 2011, 16(1): 818-846. [5]Vaidyanathan G, Affleck DJ, Zhao XG, et al. Lu-DOTA-Tyr-octreotate: A potential targeted radiotherapeutic for the treatment of medulloblastoma[J]. Curr Radiopharm, 2010, 3(1): 29-36. [6]Das T, Chakraborty S, Banerjee S, et al. On the preparation of a therapeutic dose of 177Lu-labeled DOTA-TATE using indigenously produced 177Lu in medium flux reactor[J]. Appl Radiat Isot, 2007, 65(3): 301-308. [7]Datta A, Panwar P, Chuttani K, et al. Synthesis of 99Tcm-DOTMP and its preclinical evaluation as a multidentate imaging agent for skeletal metastases[J]. Cancer Biother Radiopharm, 2009, 24(1): 123-128. [8]Hassfjell SP, Bruland OS, Hoff P. 212Bi-DOTM-P: An alpha particle emitting bone-seeking agent for targeted radiotherapy[J]. Nucl Med Biol, 1997, 24(3): 231-237. [9]Christoforidou AV, Saliba RM, Patricia Williams, et al. Results of a retrospective single institution analysis of targeted skeletal radiotherapy with 166Holmium-DOTMP as conditioning regimen for autologous stem cell transplant for patients with multiple myeloma: Impact on transplant outcomes[J]. Biology of Blood and Marrow Transplantation, 2007, 13(5): 543-549. [10] Sudipta Chakraborty, Tapas Das, Sharmila Banerjee, et al. Preparation and biological evaluation of 153Sm-DOTMP as a potential agent for bone pain palliation[J]. Nuclear Medicine Communications, 2004, 25(12): 1 169-1 176. [11]李洪玉,梁积新,罗志福,等.177Lu-EDTMP的药盒法制备、大鼠体内生物分布及显像[J].同位素,2010,23(2):65-70. [12]Tapas Dasa, Sudipta Chakrabortya, Unnia PR, et al, 177Lu-labeled cyclic polyaminophosphonates as potential agents for bone pain palliation[J]. Applied Radiation and Isotopes, 2002, 57: 177-184. [13]邓新荣,李洪玉,罗志福,等.177Lu-EDTMP和177Lu-DOTMP的标记及其骨靶向评价[J].同位素,2009,22(2):71-75. |